PBM Latest Headlines

Short Interest Alert: Most and least shorted sub-$2B healthcare stock at the end of October

at seekingalpha.com (Tue, 3-Nov 10:15 AM)

Psyence BioMed raises its PsyLabs stake to 43.37% after ibogaine milestones trigger a $2.60 million backstop investment

Market Chameleon (Wed, 21-Oct 10:50 AM)

PBM Targets U.S. Pharmaceutical-Grade Ibogaine Manufacturing Through a DEA-Registered 83,000-Sq.-Ft. Texas Facility

Market Chameleon (Mon, 5-Oct 7:52 AM)

Psyence BioMed targets a Texas ibogaine trial with a US$5 million PsyLabs investment and a US$9 million share swap

Market Chameleon (Wed, 23-Sep 7:29 AM)